TG Therapeutics Inc (TGTX)
13.99
+0.17
(+1.23%)
USD |
NASDAQ |
Apr 18, 16:00
13.81
-0.18
(-1.29%)
Pre-Market: 09:18
TG Therapeutics Price to Book Value: 13.46 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 13.46 |
| April 17, 2024 | 13.30 |
| April 16, 2024 | 13.47 |
| April 15, 2024 | 13.54 |
| April 12, 2024 | 13.62 |
| April 11, 2024 | 14.20 |
| April 10, 2024 | 14.15 |
| April 09, 2024 | 14.53 |
| April 08, 2024 | 14.40 |
| April 05, 2024 | 13.97 |
| April 04, 2024 | 13.91 |
| April 03, 2024 | 13.92 |
| April 02, 2024 | 13.89 |
| April 01, 2024 | 14.21 |
| March 28, 2024 | 14.63 |
| March 27, 2024 | 14.98 |
| March 26, 2024 | 14.86 |
| March 25, 2024 | 15.10 |
| March 22, 2024 | 14.90 |
| March 21, 2024 | 14.67 |
| March 20, 2024 | 14.79 |
| March 19, 2024 | 14.75 |
| March 18, 2024 | 14.48 |
| March 15, 2024 | 14.64 |
| March 14, 2024 | 14.78 |
| Date | Value |
|---|---|
| March 13, 2024 | 15.13 |
| March 12, 2024 | 15.24 |
| March 11, 2024 | 15.75 |
| March 08, 2024 | 16.14 |
| March 07, 2024 | 17.32 |
| March 06, 2024 | 17.54 |
| March 05, 2024 | 17.40 |
| March 04, 2024 | 17.19 |
| March 01, 2024 | 17.28 |
| February 29, 2024 | 16.57 |
| February 28, 2024 | 16.96 |
| February 27, 2024 | 13.38 |
| February 26, 2024 | 12.85 |
| February 23, 2024 | 12.82 |
| February 22, 2024 | 12.68 |
| February 21, 2024 | 12.28 |
| February 20, 2024 | 12.48 |
| February 16, 2024 | 13.05 |
| February 15, 2024 | 13.59 |
| February 14, 2024 | 13.39 |
| February 13, 2024 | 13.14 |
| February 12, 2024 | 14.32 |
| February 09, 2024 | 13.91 |
| February 08, 2024 | 13.81 |
| February 07, 2024 | 13.56 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.170
Minimum
Jun 16 2022
190.60
Maximum
May 04 2023
27.26
Average
14.48
Median
Feb 06 2024
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 19.07 |
| Geron Corp | 8.215 |
| Editas Medicine Inc | 1.301 |
| G1 Therapeutics Inc | 6.137 |
| Mersana Therapeutics Inc | 10.96 |
Price to Book Value Related Metrics
| PE Ratio | 1399.00 |
| PS Ratio | 8.889 |
| Price | 13.99 |
| Earnings Yield | 0.07% |
| Market Cap | 2.160B |
| Operating PE Ratio | 100.67 |
| Normalized PE Ratio | 1399.00 |